BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Schizas D, Mastoraki A, Naar L, Spartalis E, Tsilimigras DI, Karachaliou GS, Bagias G, Moris D. Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment. World J Gastroenterol 2018; 24(41): 4635-4642 [PMID: 30416311 DOI: 10.3748/wjg.v24.i41.4635]
URL: https://www.wjgnet.com/1007-9327/full/v24/i41/4635.htm
Number Citing Articles
1
Yuhang Xiao, Min Su, Wei Ou, Hui Wang, Bo Tian, Junliang Ma, Jinming Tang, Jie Wu, Zhining Wu, Wenxiang Wang, Yong Zhou. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancerBiomedicine & Pharmacotherapy 2019; 117: 109192 doi: 10.1016/j.biopha.2019.109192
2
Nan Huang, Chang Xu, Liang Deng, Xue Li, Zhixuan Bian, Yue Zhang, Shuping Long, Yan Chen, Ni Zhen, Guohui Li, Fenyong Sun. PAICS contributes to gastric carcinogenesis and participates in DNA damage response by interacting with histone deacetylase 1/2Cell Death & Disease 2020; 11(7) doi: 10.1038/s41419-020-2708-5
3
Asma Sindhoo Nangraj, Gurudeeban Selvaraj, Satyavani Kaliamurthi, Aman Chandra Kaushik, William C. Cho, Dong Qing Wei. Integrated PPI- and WGCNA-Retrieval of Hub Gene Signatures Shared Between Barrett's Esophagus and Esophageal AdenocarcinomaFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00881
4
Aikaterini Mastoraki, Dimitrios Schizas, Pigi Vlachou, Nikoleta Maria Melissaridou, Nikolaos Charalampakis, Rodanthi Fioretzaki, Christo Kole, Olga Savvidou, Pantelis Vassiliu, Emmanouil Pikoulis. Assessment of Synergistic Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of SarcomaMolecular Diagnosis & Therapy 2020; 24(5): 557 doi: 10.1007/s40291-020-00487-2
5
Jiang‐Hu Huang, Yang Xu, Fei‐Yue Lin. The inhibition of microRNA‐326 by SP1/HDAC1 contributes to proliferation and metastasis of osteosarcoma through promoting SMO expressionJournal of Cellular and Molecular Medicine 2020; 24(18): 10876 doi: 10.1111/jcmm.15716
6
Lyu Weidong, Luca Sanna, Valentina Bordoni, Zeng Tiansheng, Li Chengxun, Gabriele Murineddu, Gerard A. Pinna, David J. Kelvin, Luigi Bagella. Target identification of a novel unsymmetrical 1,3,4‐oxadiazole derivative with antiproliferative propertiesJournal of Cellular Physiology 2021; 236(5): 3789 doi: 10.1002/jcp.30120
7
Dimitrios Schizas, Aikaterini Mastoraki, Leon Naar, Diamantis I. Tsilimigras, Ioannis Katsaros, Vasiliki Fragkiadaki, Georgia-Sofia Karachaliou, Nikolaos Arkadopoulos, Theodore Liakakos, Dimitrios Moris. Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic RoleCurrent Medicinal Chemistry 2020; 27(36): 6099 doi: 10.2174/0929867326666190712160842
8
Yang Shi, Zheng Xiang, Huiyu Yang, Suliman Khan, Ruizhe Li, Siran Zhou, Saif Ullah, Jiyu Zhang, Bingrong Liu. Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinomaAging 2021; 13(11): 15336 doi: 10.18632/aging.203091
9
Huiwu Li, Hui Li, Yibulayin Waresijiang, Yan Chen, Ying Li, Liang Yu, Yike Li, Ling Liu. Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinomaExperimental and Therapeutic Medicine 2020; 20(1): 315 doi: 10.3892/etm.2020.8697
10
Long Liao, Zi‐Ting Yao, Wang‐Kai Fang, Qing‐Yu He, Wen Wen Xu, Bin Li. Epigenetics in Esophageal Cancer: From Mechanisms to TherapeuticsSmall Methods 2020; 4(10): 2000391 doi: 10.1002/smtd.202000391
11
Jindong Li, Chengyan Jin, Lihua Sun, Bin Wang, Peiyan Hua, Yan Zhang. HDAC2 enhances esophageal squamous cell carcinoma development through down-regulating microRNA-503-5p and promoting CXCL10Clinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01068-8
12
Gang Liu, Haiying Chen, Hua Liu, Wenbo Zhang, Jia Zhou. Emerging roles of SIRT6 in human diseases and its modulatorsMedicinal Research Reviews 2021; 41(2): 1089 doi: 10.1002/med.21753
13
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, Vasiliki E. Georgakopoulou, Panagiotis Sarantis, Efstathios A. Antoniou, Michalis V. Karamouzis, Afroditi Nonni, Dimitrios Schizas, Evangelos Diamantis, Evangelos Koustas, Paraskevi Farmaki, Athanasios Syllaios, Alexandros Patsouras, Konstantinos Kontzoglou, Nikolaos Trakas, Dimitrios Dimitroulis. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future OpportunitiesJournal of Personalized Medicine 2021; 11(3): 223 doi: 10.3390/jpm11030223
14
Dimitrios Goutas, Stamatios Theocharis, Gerasimos Tsourouflis. Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in NeoplasiaDiagnostics 2021; 11(8): 1346 doi: 10.3390/diagnostics11081346
15
Aikaterini Mastoraki, Dimitrios Schizas, Nikolaos Charalampakis, Leon Naar, Maria Ioannidi, Diamantis Tsilimigras, Maria Sotiropoulou, Dimitrios Moris, Pantelis Vassiliu, Evangelos Felekouras. Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of CholangiocarcinomaMolecular Diagnosis & Therapy 2020; 24(2): 175 doi: 10.1007/s40291-020-00454-x